Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 49, 2019 - Issue 4
362
Views
7
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Absorption, disposition, metabolism and excretion of [14C]mizagliflozin, a novel selective SGLT1 inhibitor, in rats

, , , , &
Pages 463-473 | Received 10 Jan 2018, Accepted 04 Mar 2018, Published online: 28 Mar 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Seiichi Yamamoto, Hideki Tomita, Ryohei Terabayashi, Kenji Yoshida, Kouhei Nakanishi, Takako Furukawa, Kei Kamada & Akira Yoshikawa. (2022) In-vivo imaging of a mouse by detecting bremsstrahlung X-rays from 14C using a La-GPS imaging system. Journal of Nuclear Science and Technology 59:11, pages 1436-1447.
Read now
Jill E. Elwing, Hadi Atassi, Benjamin D. Rogers & Gregory S. Sayuk. (2022) Emerging therapies in the management of Irritable Bowel Syndrome (IBS). Expert Opinion on Emerging Drugs 27:1, pages 55-73.
Read now

Articles from other publishers (5)

Michael Camilleri. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 76 99 .
Na Lin, Hui Lin, Qi Yang, Wenqiang Lu, Zhenzhu Sun, Shimin Sun, Liping Meng, Jufang Chi & Hangyuan Guo. (2021) SGLT1 Inhibition Attenuates Apoptosis in Diabetic Cardiomyopathy via the JNK and p38 Pathway. Frontiers in Pharmacology 11.
Crossref
Michael Camilleri. (2019) What’s in the pipeline for lower functional gastrointestinal disorders in the next 5 years?. American Journal of Physiology-Gastrointestinal and Liver Physiology 317:5, pages G640-G650.
Crossref
Shin Fukudo & Kohei Kaku. (2019) Effect of Mizagliflozin on Postprandial Plasma Glucose in Patients With Functional Constipation. Journal of Neurogastroenterology and Motility 25:2, pages 332-333.
Crossref
Shin Fukudo, Yuka Endo, Michio Hongo, Atsushi Nakajima, Tatsuya Abe, Hiroyuki Kobayashi, Tomohiro Nakata, Toshio Nakajima, Kanako Sameshima, Kohei Kaku, Etsuro Shoji, Ken Tarumi, Yasuhiro Nagaoka, Tetsuo Ooshima, Kotaro Ozawa, Takashi Majima, Shigeyasu Kamata, Tomohiro Tada, Hiroshi Ishii, Yutaka Segawa, Shinichi Miyazaki, Takashi Yamamoto, Yoshinori Yagi, Hideo Sawada, Shigeru Shirota, Seiji Otsuka, Norimichi Yamada, Ryoichi Suzuki, Hidenori Kurakata, Katsuhiko Nakai, Yamasaki Syuji, Tatsuhiko Usui, Makoto Yamamura, Tatsuhiro Oishi & Hiroaki Tanaka. (2018) Safety and efficacy of the sodium-glucose cotransporter 1 inhibitor mizagliflozin for functional constipation: a randomised, placebo-controlled, double-blind phase 2 trial. The Lancet Gastroenterology & Hepatology 3:9, pages 603-613.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.